• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.一种新型苯异硫氰酸酯托烷类似物与大鼠脑中单胺转运体的不可逆结合。
Biochem Pharmacol. 2007 Jul 15;74(2):336-44. doi: 10.1016/j.bcp.2007.04.019. Epub 2007 Apr 27.
2
In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain.新型苯基异硫氰酸酯托烷类似物在大鼠脑单胺转运体上的体内特性研究
J Pharmacol Exp Ther. 2008 Aug;326(2):587-95. doi: 10.1124/jpet.108.138842. Epub 2008 May 20.
3
Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.关于一系列新型(S)-2β-取代的3α-[双(4-氟-或4-氯苯基)甲氧基]托烷类似物的构效关系研究,用于体内研究。
J Med Chem. 2006 Oct 19;49(21):6391-9. doi: 10.1021/jm060762q.
4
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.生物胺转运体的研究。10. 从多巴胺转运体基因敲除小鼠制备的脑膜中一种新型可卡因结合位点的特性研究。
Synapse. 2002 May;44(2):94-105. doi: 10.1002/syn.10060.
5
Novel tropane-based irreversible ligands for the dopamine transporter.新型基于托烷的多巴胺转运体不可逆配体。
J Med Chem. 2001 Dec 6;44(25):4453-61. doi: 10.1021/jm0101904.
6
Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.生物胺转运体的研究。VII. 用[125I]RTI-55在人、猴和豚鼠尾状核制备的膜中鉴定出的一种新型可卡因结合位点的特性。
Synapse. 1998 Apr;28(4):322-38. doi: 10.1002/(SICI)1098-2396(199804)28:4<322::AID-SYN8>3.0.CO;2-B.
7
Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.2,3-二芳基托烷的合成及单胺转运体结合特性
J Med Chem. 2005 Nov 17;48(23):7437-44. doi: 10.1021/jm0582423.
8
Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.单胺转运体对偏侧帕金森病大鼠左旋多巴效应的作用。
Neuropharmacology. 2016 Nov;110(Pt A):125-134. doi: 10.1016/j.neuropharm.2016.07.025. Epub 2016 Jul 21.
9
Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.接触托烷类药物后多巴胺和5-羟色胺转运体的长期抑制
Neuropharmacology. 1998;37(1):123-30. doi: 10.1016/s0028-3908(97)00194-9.
10
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.莫达非尼在体内占据多巴胺和去甲肾上腺素转运体,并在体外调节这些转运体和痕量胺活性。
J Pharmacol Exp Ther. 2006 Nov;319(2):561-9. doi: 10.1124/jpet.106.106583. Epub 2006 Aug 2.

引用本文的文献

1
Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.阿齐碘代-N-苄基麦角酸二乙酰胺(利他林、专注达)衍生物:合理设计、合成、药理学评价及多巴胺转运体光亲和标记。
Bioorg Med Chem. 2011 Jan 1;19(1):504-12. doi: 10.1016/j.bmc.2010.11.002. Epub 2010 Nov 4.
2
A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.一种基于吡咯戊酮的新型多巴胺转运体光亲和配体。
Bioorg Med Chem. 2009 Jun 1;17(11):3770-4. doi: 10.1016/j.bmc.2009.04.057. Epub 2009 May 3.

本文引用的文献

1
Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter.可卡因类似物[125I]RTI 82与多巴胺转运体跨膜结构域6的不可逆结合定位
J Biol Chem. 2007 Mar 23;282(12):8915-25. doi: 10.1074/jbc.M610633200. Epub 2007 Jan 25.
2
Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 (N-fluoroalkyl) labeled 2beta-carbomethoxy-3beta-(4'-(3-furyl)phenyl)tropanes and -nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.碳-11和氟-18(N-氟烷基)标记的2β-甲氧基羰基-3β-(4'-(3-呋喃基)苯基)托烷和去甲托烷的合成、放射性合成及生物学评价:用于正电子发射断层扫描体内成像5-羟色胺转运体的候选放射性配体
J Med Chem. 2005 Nov 3;48(22):7080-3. doi: 10.1021/jm0504095.
3
Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.放射性配体与去甲肾上腺素转运体结合的药理学特征:功能活性指示不佳的实例。
J Neurosci Methods. 2005 Apr 15;143(1):87-94. doi: 10.1016/j.jneumeth.2004.09.015.
4
Affinity labeling the dopamine transporter ligand binding site.亲和标记多巴胺转运体配体结合位点。
J Neurosci Methods. 2005 Apr 15;143(1):33-40. doi: 10.1016/j.jneumeth.2004.09.022. Epub 2004 Dec 2.
5
Novel approaches to the treatment of cocaine addiction.治疗可卡因成瘾的新方法。
CNS Drugs. 2005;19(1):13-25. doi: 10.2165/00023210-200519010-00002.
6
Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.[(18)F]β-CFT-FE(2β-甲氧基羰基-3β-(4-氟苯基)-8-(2-[(18)F]氟乙基)去甲托烷)作为多巴胺转运体配体的潜力:清醒猴脑的正电子发射断层扫描(PET)研究
Synapse. 2004 Oct;54(1):37-45. doi: 10.1002/syn.20059.
7
Agents in development for the management of cocaine abuse.正在研发用于治疗可卡因滥用的药物。
Drugs. 2004;64(14):1547-73. doi: 10.2165/00003495-200464140-00004.
8
Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.具有可卡因抗性且多巴胺摄取正常的多巴胺转运体突变体为可卡因拮抗作用提供了靶点。
Mol Pharmacol. 2002 Apr;61(4):885-91. doi: 10.1124/mol.61.4.885.
9
Novel tropane-based irreversible ligands for the dopamine transporter.新型基于托烷的多巴胺转运体不可逆配体。
J Med Chem. 2001 Dec 6;44(25):4453-61. doi: 10.1021/jm0101904.
10
The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.摄取抑制剂可卡因和苯海索对人类多巴胺转运体的构象有不同影响。
J Biol Chem. 2001 Aug 3;276(31):29012-8. doi: 10.1074/jbc.M011785200. Epub 2001 Jun 6.

一种新型苯异硫氰酸酯托烷类似物与大鼠脑中单胺转运体的不可逆结合。

Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

作者信息

Murthy Vishakantha, Davies Huw M L, Hedley Simon J, Childers Steven R

机构信息

Department of Physiology/Pharmacology, Center for the Neurobiological Investigation of Drug Abuse, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States.

出版信息

Biochem Pharmacol. 2007 Jul 15;74(2):336-44. doi: 10.1016/j.bcp.2007.04.019. Epub 2007 Apr 27.

DOI:10.1016/j.bcp.2007.04.019
PMID:17540345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4701044/
Abstract

Irreversible tropane analogs have been useful in identifying binding sites of cocaine on biogenic amine transporters, including transporters for dopamine (DAT), serotonin (SERT) and norepinephrine (NET). The present study characterizes the properties of the novel phenylisothiocyanate tropane HD-205, synthesized from the highly potent 2-napthyl tropane analog WF-23. In radioligand binding studies in brain membranes, direct IC(50) values of HD-205 were 4.1, 14 and 280nM at DAT, SERT and NET, respectively. Wash-resistant binding was characterized by preincubation of HD-205 with brain membranes, followed by extensive washing before performing transporter radioligand binding. Results for HD-205 showed wash-resistant IC(50) values of 191, 230 and 840nM at DAT, SERT and NET, respectively. Saturation binding studies with [(125)I]RTI-55 in membranes pretreated with 100nM HD-205 showed that HD-205 significantly decreased the B(max) but not K(D) of DAT and SERT binding. To further characterize its irreversible binding, an iodinated analog of HD-205, HD-244, was prepared from a trimethylsilyl precursor. The direct IC(50) of HD-244 at DAT was 20nM. [(125)I]HD-244 was synthesized with chloramine-T, purified on HPLC, reacted with rat striatal membranes, and proteins were separated by SDS-PAGE. Results showed several non-specific labeled bands, but only a single specific band of radioactivity co-migrating with an immunoreactive DAT band at approx. 80 kilodaltons was detected, suggesting that [(125)I]HD-244 covalently labeled DAT protein in striatal membranes. These results demonstrate that phenylisothiocyanate analogs of WF-23 can be used as potential ligands to map distinct binding sites of cocaine analogs at DAT.

摘要

不可逆的托烷类似物在确定可卡因在生物胺转运体上的结合位点方面很有用,这些转运体包括多巴胺(DAT)、5-羟色胺(SERT)和去甲肾上腺素(NET)的转运体。本研究描述了由高效的2-萘基托烷类似物WF-23合成的新型苯基异硫氰酸酯托烷HD-205的特性。在脑膜的放射性配体结合研究中,HD-205在DAT、SERT和NET处的直接半数抑制浓度(IC50)值分别为4.1、14和280nM。耐洗涤结合的特征是将HD-205与脑膜预孵育,然后在进行转运体放射性配体结合之前进行大量洗涤。HD-205的结果显示,在DAT、SERT和NET处耐洗涤的IC50值分别为191、230和840nM。在用100nM HD-205预处理的膜中,用[125I]RTI-55进行的饱和结合研究表明,HD-205显著降低了DAT和SERT结合的最大结合量(Bmax),但不影响解离常数(KD)。为了进一步表征其不可逆结合,从三甲基硅烷基前体制备了HD-205的碘化类似物HD-244。HD-244在DAT处的直接IC50为20nM。用氯胺-T合成[125I]HD-244,通过高效液相色谱法纯化,与大鼠纹状体膜反应,然后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分离蛋白质。结果显示有几条非特异性标记带,但仅检测到一条与免疫反应性DAT带共迁移的单一放射性特异性带,其分子量约为80千道尔顿,这表明[125I]HD-244共价标记了纹状体膜中的DAT蛋白。这些结果表明,WF-23的苯基异硫氰酸酯类似物可作为潜在配体,用于绘制可卡因类似物在DAT上的不同结合位点。